Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
China Automotive Systems Announces Annual Meeting on September 24, 2024
2024-09-16 18:00
Akeso's Ivonescimab plus Chemo in First-Line Triple-negative Breast Cancer Showed Promising Preliminary Efficacy and Good Safety at ESMO 2024
2024-09-16 15:35
Autoliv Appoints Adriana Karaboutis to its Board of Directors
2024-09-16 14:53
Alphamab Oncology Presented the Latest Clinical Data from Two Studies on Anti-HER2 Bispecific ADC JSKN003 at the ESMO Congress 2024
2024-09-16 13:03
Risen Energy Champions Environmental Stewardship for a Greener Future
2024-09-16 10:00
Temple Mall Presents "Blue-and-White Porcelain Impressions" Art Experience
2024-09-16 09:00
Akeso Published Ivonescimab plus Ligufalimab as First-Line Treatment for PD-L1-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at ESMO 2024
2024-09-15 15:10
CNOOC Limited Successfully Withstands Super Typhoon "Yagi"
2024-09-15 10:41
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
2024-09-14 19:43
Gan & Lee Pharmaceuticals Presented Two Positive Clinical Results of Once-weekly Insulin GZR4 at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD 2024)
2024-09-14 19:00
TIME, Statista Name Three SM companies Among World's Best Companies
2024-09-14 17:04
Harbour BioMed Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024
2024-09-14 16:06
Sinopec Wins Best Environmental Protection Case at the First Sino-European Corporate ESG Best Practice Conference in Frankfurt
2024-09-14 12:23
XCMG Unveils Major Lineup for MinExpo 2024, Showcasing Advanced Mining Solutions
2024-09-14 11:19
Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation
2024-09-14 08:18
Learning Tree International Celebrates 50 Years of Innovation, Impact, and Excellence
2024-09-14 07:01
Planet Image International Limited Reports the First Half of Fiscal Year 2024 Unaudited Financial Results
2024-09-14 04:45
TOPBAND@2024 RE+, Exploring the Infinite Possibilities of Clean Energy
2024-09-13 21:00
111 Inc. Announces Its Co-founders' Strategic Share Purchase and Highlights Continued Growth and Innovation
2024-09-13 19:30
Cheetah Mobile Announces Second Quarter 2024 Unaudited Consolidated Financial Results
2024-09-13 17:00
1
62
63
64
65
66
3395